REQUEST A DEMO
Total
USD $0.00
Search more companies

Aether Biotech Sp. z o.o. (Poland)

Main Activities: Medical Equipment and Supplies Manufacturing
Secondary Activities: Semiconductor and Other Electronic Component Manufacturing | Engineering Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Aether Biotech Sp. z o.o. Profile Updated: June 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Aether Biotech Sp. z o.o. is a company in Poland, with a head office in Poznan. The company operates in the Medical Equipment and Supplies Manufacturing industry. The company was established on June 04, 2019. There was a total growth of 27.64% in Aether Biotech Sp. z o.o.’s total assets over the same period.

Headquarters
Ul. Mostowa 11
Poznan; Wielkopolskie; Postal Code: 61-854

Contact Details: Purchase the Aether Biotech Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Aether Biotech Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Aether Biotech Sp. z o.o. report to view the information.
Incorporation Date:
June 04, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
92.86%
Company Performance
Financial values in the chart are available after Aether Biotech Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating Profit/Loss (EBIT)
-8.42%
EBITDA
-8.42%
Net Profit/Loss for the Period
-8.42%
Total Assets
27.64%
Total Equity
-298.21%
Return on Equity (ROE)
-200.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?